| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 45,655 | 49,362 | 46,618 | 60,828 | | Cost of Revenue | 18,608 | 19,724 | 19,773 | 27,442 | | | Gross Profit | 27,047 | 29,638 | 26,845 | 33,386 | | | Operating Expenses | | Research Development | 5,396 | 5,735 | 5,937 | 6,158 | | Selling General and Administrative | 19,229 | 20,074 | 20,898 | 22,464 | | Non Recurring | 3,218 | 1,368 | 1,797 | 58,362 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,612 | 2,461 | (1,787) | (53,598) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,892) | (959) | 1,657 | (4,951) | | Earnings Before Interest And Taxes | (2,545) | 1,502 | (130) | (58,549) | | Interest Expense | 8,562 | 8,729 | 8,516 | 10,654 | | Income Before Tax | (11,107) | (7,227) | (8,646) | (69,203) | | Income Tax Expense | (2,133) | 377 | 85 | (4,551) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,974) | (7,604) | (8,731) | (64,652) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,974) | (7,604) | (8,731) | (64,652) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,974) | ($7,604) | ($8,731) | ($64,652) |
|
0.03% Nasdaq 
Income Statement
